Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 6 months of age.
- People whose tumor tissue has been tested and confirmed to have a specific protein called CD44v6 present, detected through laboratory testing of a tissue or blood sample.
- People who are in reasonably good general health (as measured by a standard medical score) and whose doctors estimate they have a life expectancy of more than 3 months.
- People whose heart, liver, and kidneys are functioning well enough to meet specific laboratory test thresholds set by the trial (confirm specific values with trial site).
- People whose hemoglobin (a measure of healthy red blood cells) is at or above a certain level (confirm with trial site).
- People who do not have any medical reasons that would prevent a cell separation procedure.
- People who are able to understand the trial and are willing to sign a written consent form.
Who may not be able to join:
- People with a serious illness or medical condition — including an active, uncontrolled infection — that would make it unsafe to follow the trial's treatment plan.
- People with an active bacterial, fungal, or viral infection that is not being adequately controlled by treatment.
- People with a known diagnosis of HIV, hepatitis B, or hepatitis C.
- People who are pregnant or currently breastfeeding.
- People who have used steroid medications (glucocorticoids) taken throughout the whole body within one week before entering the trial.
- People who have already received a treatment specifically targeting the CD44v6 protein.
- People whom the trial investigators believe may not be able to follow the requirements of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of infusion; Clinical response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.